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Abstract
In this chapter, we will discuss the design and development of a patient passport
mHealth application for Cystic Fibrosis adults from ideation to app-store release. By
allowing the patients access to their own unique data, it is anticipated that it will be
of benefit when travelling abroad and between CF centres. The design process
followed a pipeline we developed that is informed by patient and healthcare pro-
fessional input. The app structure resembles an Irish patient file and is divided into
three categories: “My CF Info”, “My Medical History”, and “My Clinical Appoint-
ments”. My CF Info allows the patient to store personal information such genotype,
medical team contact information, physiotherapy, allergies, and medications. My
Medical History allows the user to record information such as CF renal disease, CF
diabetes, and the insertion/removal of a portacath/gastrostomy tube. My Clinical
Appointments allows the user to record the type of appointment (annual assess-
ment, clinic, other) and all information that would ordinarily be inserted into a
patient file such as weight, height, spirometry and other comments. Weight and
lung function are also displayed in a plot graph. The app has undergone pilot testing
with five CF adults before being rolled out onto the Google Play Store.
Keywords: cystic fibrosis, patient passport, mHealth, digital health,
self-management
1. Introduction
Cystic Fibrosis (CF) is the most common life limiting genetic disease affecting
Caucasians. Patients must adhere to rigorous therapies in order to manage their
condition. Such therapies include airway clearance physiotherapy, medications,
diet, and exercise.
Ireland has the highest prevalence of CF worldwide, with 1 in 19 people being
carriers for the CF gene [1]. Despite this, the life expectancy of patients with CF is
rising. A child born with CF in 2009 is now predicted to live into their 50s [4, 5],
compared to children born in 1950, of which half would live to the age of 16 and
only 3% to 25 years old [2, 3]. However, this increase in life expectancy comes with
an increase in patient population. There are now more adult CF patients than
pediatric patients in Ireland [6]. It is projected that the pediatric service will need to
grow by 25% and the adult service by 75% by 2025 [7]. This growth in adult
population and the advent of ICT technologies in the medical space has led to
mobile health applications (mHealth apps) being identified as potential powerful
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tools to assist the growing and ageing CF population in the management of their
condition. However, any mHealth app developed in this way must be fully
personalisable in order to fit the heterogeneous nature of the treatment and man-
agement of CF.
In this chapter we will discuss the design and development of a patient passport
mHealth app for CF adults; from ideation to app-store release. This chapter will
first begin by introducing the CF unit responsible for its development, before
discussing patient passports. Following this, the chapter will introduce the
development of this mHealth app which follows the mHealth Design Pipeline as
presented by Vagg et al. [8].
1.1 Cork CF multidisciplinary team
CF clinical care is driven by a multidisciplinary team approach. The CF
Multidisciplinary Team (MDT) comprises of a mixture of healthcare professionals
with varied skill sets to support this multisystem condition. This includes a CF nurse
specialist (designated and working full time in CF care), CF physiotherapist (des-
ignated and working full time in CF care), and CF dietician (designated and
working full time in CF care). The team is supported by a respiratory technician
(with a commitment to CF) and psychologist. The MDT is medically-lead by a
respiratory specialist with an interest in CF. The respiratory physician/specialist is
also supported by a lung-disease research/specialist registrar [9].
The CF MDT at the Cork University Hospital includes: three CF nurse specialists
(>30 years collective full time experience in CF care), one dietician (>10 years full
time experience in adult and pediatric CF care) one senior physiotherapist (>5 years
full time experience CF care), one respiratory technician (>20 years full time
experience), and one CF consultant with 10 years as the director of the Cork
unit and 10 years’ experience in other leading centers both nationally and
internationally.
This multidisciplinary team supports the second largest CF center in Ireland
with over 180 adult CF patients. The Cork CF multidisciplinary team also lead
CFMATTERS; an international multicenter consortium exploring antibiotic thera-
pies in CF [10]. In addition to this, the research team includes a dedicated
medical-multimedia research specialist who works directly with the MDT.
1.2 Patient passports definition and review
A patient passport is described by the National Quality Forum (NQF) and
Health Service Executive (HSE) as a paper-based system which provides immediate
and important information regarding a patient’s health or condition to medical pro-
fessionals [11, 12]. This passport system is implemented for a number of reasons,
such as improved patient experience, improving the speed that care is delivered,
and as a solution for those patients with learning disabilities [11, 12].
An example of such a passport can be seen for asthma management in the
research conducted by Newell et al. [13]. The paper-based passport as presented in
this research is developed to store pertinent medical information that an asthmatic
would require to receive care on entering an emergency room. Newell et al. found
that patients would often experience more fear and stress in this situation as
responding medical professionals may ask the patient to repeatedly speak to gain an
understanding of this patient’s condition, or leave the patient alone so that they can
source the information. The paper passport solution is designed to be small and
convenient to carry (the size of a credit card) and can provide medical professionals
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the medical data needed to treat the patient immediately [13]. Another example
of these paper-based passports can be seen in the research carried out by Barber
et al. [14]. This passport was developed as a medication aid and allowed geriatric
patients to record and review their medications and dosages. The researchers
found that this system empowered patients to be more in control of their
medication and also acted as a mechanism for the patient to communicate and
discuss their medications more confidently with their medical team [14].
Patient passports have also been created for other long-term conditions, such as
diabetes. Similar to other chronic conditions, diabetic patients must meet with
various members of the multidisciplinary healthcare team. For diabetic patients,
passports can be beneficial as they allow the patient to record medical data received
from each member of the diabetes multidisciplinary team [15]. In this way, pass-
ports bridge a communication gap between patients and these various multidis-
ciplinary members [15].
When researching “CF Patient Passports”, only two bodies of work were found.
The first was a book titled “The Cystic Fibrosis Passport” by Fitzgerald, which aims
to aid family members in understanding the needs of children with cystic fibrosis,
and to serve as a practical guide to those who care for these children [16]. The
second was a quality improvement initiative taken by the Stanford CF Center,
which presented a paper-based system that used a passport-sized document
containing instructions on how to care for a patient with CF [17]. The document
could be presented by a CF patient to a hospital or clinic to ensure the correct
measures are taken to avoid potential issues with infection and cross-
contamination. Although both passports are important for the care of CF, they do
not include features common to long term condition passports as they do not
facilitate self-reported medical data that is accessible to patients at all times.
In addition to paper-based CF passports, a search was performed for digital CF
patient passports on both the Google Play and iOS mobile App Stores. From this
search, only one app was found that allows CF patients to record their medical data,
similar to a passport; “CF View” [18]. CFView is an app which was created by “CF
Ireland”, a CF charity in the Republic of Ireland. The app allows patients to view
medical data that has been collected regarding their condition; however, it does
not allow patients to enter or save data. In addition to this, CF patients can only use
this app if they are part of a CF registry in Ireland, Denmark or Slovenia, and
have been issued with an account by that registry. From the findings of the paper
based and digital based search, it would appear that there is no freely or publicly
available CF patient passport system that allows patients to record basic medical
data. Considering the benefits of a patient passport, it can be stipulated that
such a tool would be beneficial to adult CF patients.
1.3 Possible issues with patient passports
The previous section outlines cases where patient passports have been used
advantageously for patients; asthma patient information, diabetic patient informa-
tion, medication aid. However, patient passports can also present other challenges
which may lead to low adoption rates and minimal impact on patient experience. To
investigate this further, Dijkstra et al. interviewed diabetic patients and medical
professionals to understand their experience of implementing the passport into
their current care system [19]. Concerns expressed by the patients were predomi-
nantly focused on security, forgetting the passport, being over encumbered, and
need for additional time to enter information into the passport. For security,
patients were concerned of the ramifications of losing the passport and the threat
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this may have on identity theft. Furthermore, some paper passports can be the size
of a small A5 copy and cannot fit into a pocket easily. For this reason, patients
expressed concerns with forgetting to bring the passport to clinical appointments
and also friends or work colleagues seeing or finding the passport. As for time,
patients felt that entering information into the passport could often take away from
the valuable time they had with their healthcare team [19].
When interviewing medical professionals Dijkstra et al. found that often there
was no clear agenda for the passport and how it would be of benefit to patient self-
management. Consequently, it was unclear at which stage a passport should be
introduced formally to a patient to ensure they know how to use it sufficiently.
Moreover, there are discrepancies over who is responsible to manage the passport,
if it is of benefit to medical professionals, and how this passport can be
implemented seamlessly to the current healthcare system [19].
2. Patient mHealth survey
The General mHealth Design Pipeline [8] first suggests gathering insights from
key stakeholders to mHealth applications (patients and medical professionals). As
such a survey is conducted with CF adult patients from the Cork University Hospi-
tal to include their insights before developing a written report with medical pro-
fessionals. To evaluate if CF adults would find an mHealth app beneficial and to
determine what aspect of patient education and patient management that is of
interest to CF adult patients, an 18-part multiple choice survey was created and
validated over a series of three formal meetings with the Cork CF multidisciplinary
(see appendix). Participation in this survey was voluntary, and the inclusion criteria
for this survey were that participants were 18 years old or older and owned a
smartphone. Surveys were offered to all patients attending their designated outpa-
tient appointment over a 4 week period at the CF Day Ward in Cork University
Hospital. Ethical approval for this survey is obtained via the Clinical Research Ethics
Committee in University College Cork. During the study period, 49 eligible patients
completed the survey; no patients opted-not to complete the survey. The collected
survey data was anonymized, and the only clinical information collected in this
survey was that the participants have CF and are attending the Cork CF center.
2.1 Survey results
A total of 49 completed surveys were analyzed. Of the 49 participants, 55% of
respondents use an Android smartphone and 40% use an iPhone. It was reported
that 38% of participants have a mHealth app installed on their smartphone device
such as exercise trackers or calorie counters; however, only 10% (n = 5) know of
or are aware of an app which targets CF. Those CF focused mHealth apps identified
by the participants are “CF MedCare”, “MyFitnessPal”, “CFMATTERS STUDY
INFO”, and “CF View”. Two of the five participants reported having a CF app
installed on their phone (CF View and CF MedCare). The remaining 44 participants
who do not know of any CF apps or have a CF app installed were then asked to
explain their answer. Of the 44 participants, 20 patients reported being unaware
of the existence of CF apps; “I don’t think there is one”, and three advised that they
are not interested in a CF app; “Not Interested”.
The participants are also given the option to choose multiple aspects of their
CF that they would like targeted by a CF mHealth app. To note, the participants
could choose as many of these options as applicable. It was found that “New
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Research Developments” (55%), “Medication” (55%), and “Physiotherapy” (47.5%)
are the areas of most interest to the participants, followed by “Diet” (42.50%),
“Monitoring” (40%), “Social Networks” (40%), “Self-Psychological Help”
(37.50%), “News” (32.50%), “Education” (27.50%), and “Management” (20%).
One patient reported “None” for this question.
Further questions were presented regarding specific features within mHealth
applications. 85% of participants agreed that they would like to receive notifications
from the app, such as reminders to take medication or next clinical appointment.
When asked would the participant play a game to support their CF, the results were
more dispersed; 32.65% agreed they would play a game, 34.69% reported they
would not and 30.61% were unsure. Ten of the 49 participants reported as being
part of a clinical trial currently or in the past. Six of these 10 participants reported
that an mHealth application would have been of use to this trial for data collection
or self-reporting.
A series of questions regarding the collection of personal medical data was then
presented. When asked if their CF medical information, such as genotype and
medical history, is difficult to remember, 32.65% of participants regarded this
information as difficult and 42% regarded this information as easy to remember.
26.5% of participants agreed they would record their medical information in a
mHealth app. 46.9% agreed they would store this information if the mHealth app is
password protected and 16% (n = 8) agreed they would if the mHealth app is
password protected and does not have access to the internet. One participant
reported being unsure to recording their medical data. Each participant was then
given the option to further explain their reasoning for choosing their security
preference. These results are listed below.
• Yes: If password protected
◦ “Security is priority”
◦ “Only available to me and no online servers”
◦ “Privacy Matters”
◦ “As long as it is stored on a secure database”
• Yes: If password protected and does not connect to the internet
◦ “It would be very helpful/useful to store the data for myself but I would be
cautious about who else could access it “
◦ “It is personal information and so it would need to be very secure “
◦ “It is personal and private info “
• Unsure
◦ “Security Issue”
To note, two additional answers were submitted for “Yes: If password
protected”; however, these answers were specific to the perceived usefulness of such
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an mHealth application and not their rationale for their security preference and
hence negated from the above list. The two submitted answers include: “Handy if
required when travelling/emergencies” and “It would help to track what might have been
working at the time to maintain lung function (e.g. meds/physio)”. In a follow up
question specific to the usefulness of such an application, 87.5% of participants
reported that they would find it beneficial to have access to their medical data
through an mHealth app. Of the 49 participants 67.35% agreed that an mHealth
app that recorded their medical data would be useful and 61.22% confirmed they
would use an app to record this data.
Two questions were also posed regarding travel and admission to the accident
and emergency department in a hospital to determine scenarios in which the
recording of medical information would be of benefit (similar to other passports as
discussed earlier). 75.5% of participants reported having gone travelling outside of
Ireland and only 12 participants have had to visit a hospital emergency room due
their CF. When the participants were asked if they would use a CF mHealth app if
created, 67.5% said yes; however, 27.5% were unsure.
Lastly, the participants were given the option to share what they felt a CF
mHealth app should target. Twenty three participants suggested mHealth apps
which can be categorized under three headings; Management, Support, and Infor-
mation. Sixteen participants suggested management apps to track and store their
medical information to aid in self-management of the condition. Examples of this
category include “Medication taken/taking” and “Medical Info i.e weight lung fx exer-
cise + diet plans”. Six participants suggested apps that can access medical informa-
tion such as drug names and new treatments or research. An example of this
category includes “Proper medical names of meds” and “New treatments”. Lastly, five
participants suggest apps which can allow for support among CF patients, similar to
social networks; “Experience/Information sharing between other patients”.
2.2 Survey discussion
It is noted that slightly more patients own an Android device; however, the
number of iPhone owners was still high. The first observation to note from the
survey results is the paucity in awareness of CF apps. Only five patients reported
being aware of CF mHealth apps, and only two patients have these apps installed.
To note one of the apps, “MyFitnessPal”, which was regarded as a CF specific
mHealth app, is not. This app does not target any specific cohort and includes
personalisable goal setting, such as weight gain, weight loss, weight maintenance.
When questioned further this seemed to be primarily due to being unaware of such
apps; “I don’t think there is any”. However, despite this lack of awareness, the CF
adult participants still demonstrated interest and expectations on what a CF app
should focus on. New Research Developments, Medication, and Physiotherapy
focused apps were of the most interest to these participants. Additionally, tracking
medical data and receiving alerts or reminders were the most popular features.
It is important to note that the participants demonstrated concerns regarding
data security and as such any mHealth app created for these patients will need to be
fully transparent i.e full disclosure on what data is being collected, who is it being
used/viewed by, and the security measures in place.
Personalizing educational content in this way is synonymous with patient man-
agement mechanisms and interventions, as the multimedia is educating the patient
on their medical condition data or personal symptoms. Examples of patient man-
agement interventions include: audio tapes, booklets, patient credit card/patient
passports, counseling, exercise sessions, individual plan/goal setting, manuals,
videos, and lectures/talks [20].
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3. App design
3.1 Considerations from similar passports
The issues with patient passports, as listed in the Section 1.3, pertain to diabetes
passports only; however, these problems are transferable. As such, they have been
considered in the design of the adult cystic fibrosis passport. Firstly, by deploying
the CF passport as a mobile app a number of these pitfalls may be resolved. When
considering the concerns the patients expressed for security and the possibility of
identity theft, an mHealth passport can be secured via a username and password.
Furthermore, if the phone was lost or stolen, all passport data will be encrypted and
not easily accessible. As the passport will be in a digital form on a smartphone,
issues regarding the patient being over encumbered or finding it difficult to carry
the passport on their person are removed. Furthermore, as the data entered into the
mHealth passport is minimal, there will be no smartphone memory usage issues.
Finally, as the passport will be in an mHealth form, it is unlikely that a patient will
forget their smartphone and subsequently reduces the risk of forgetting the pass-
port at clinical appointments.
3.2 Considerations from MDT meeting
The remaining issues, as highlighted by members of the diabetes healthcare
team, were discussed with cystic fibrosis nurse specialists at the Cork University
Hospital. The below discussed solutions were work shopped and agreed upon by
consensus before being implemented into the app design. Firstly, identifying the
point of care the app should be introduced was considered. In the current healthcare
model, the passport shall be introduced to patients who have just transferred from
pediatric to the adult orientated facility. However, the app can also be introduced to
existing adult patients. During this introduction, a CF nurse specialist will explain
the aim of this app and why it will be of use to the patient, the data that can be
entered into the passport, and when/how to use this app when meeting members of
their healthcare team. The nurse will then assist the patient in entering data that can
help set up their profile in the app (e.g. contact information for their healthcare
team, genotype). The patient will then be made aware that all data entered into the
app is voluntary and cannot be viewed outside the app. The nurse will also explain
to the patient that the patient is responsible for entering data into the app.
Finally, concerns surrounding time to enter information into the passport was
discussed. In Ireland, An adult CF clinic appointment can last approximately 1 hour
and 15 minutes. During this clinic, patients meet each member of the MDT. The
first member of this team is a CF nurse specialist who will encourage the patient to
enter the data into their passport while the nurse enters the data into their patient
file. Between meeting each member of the MDT there is approximately 15 minutes
of free time. Therefore, if similar to the diabetic patients, the CF patients feel as
though they would prefer to spend the time with the medical team member, they
can enter the information during this free time instead.
Considering the benefits of a patient passport and the patient insight provided
by the Patient mHealth Survey, it can be stipulated that such a tool would be
beneficial to adult CF patients. Hence, this research will develop and evaluate a
patient passport targeted at adults with cystic fibrosis. However, unlike the afore-
mentioned passports, the proposed passport will be developed as a mobile applica-
tion. The agenda for this app is to provide CF adults with their basic medical
information and also to allow them to record their medications, along with medical
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data from clinical appointments. In doing this, adult CF patients may become more
aware of their condition and symptoms. Additionally, three scenarios have been
identified in which the proposed app may be of use to a CF adult. Firstly, it can
allow a patient to receive immediate care when travelling abroad. Secondly, it will
allow patients to receive care if travelling between adult CF centers. Lastly, it can be
used to communicate between healthcare team members. These scenarios and the
design of the passport app with reference to the General mHealth Design Pipeline
will be discussed further in the following section.
4. General mHealth design pipeline overview
This section will discuss the design and development of the app under the
headings Preparation, Back-End, Front-End, and Deployment, in accordance to the
mHealth Design Pipeline described by Vagg et al. [8]. To note, a series of informal
scoping meetings was held with the CF nurse specialists from the Cork adult CF unit
(>10). Post initial development a further formal meeting with the entire CF
multidisciplinary team was held to sign off on the CF passport app.
4.1 Preparation
Before developing or designing the CF Patient Passport, the app’s purpose, app
type, ethics, and regulations are defined. These considerations are discussed and
outlined in the proceeding sub-sections.
4.1.1 Purpose
This section will discuss the components necessary to create a written report
before developing the app. Firstly and agenda for the mHealth passport is outlined,
so that the app can be implemented into the current health care model and have a
positive impact on the patient. Identifying the proposed agenda of the app was
discussed with members to serve the patient were identified and are listed below.
Scenario 1 Traveling between CF centers: In Ireland, there are five CF focused
centers. Patients can transfer between these centers for varying medical or personal
reasons. However, as patient data is stored as a hardcopy, there may be a delay
between the patient arriving at the center and the medical professional accessing
their clinical data. In this scenario, the mHealth passport can ensure that the patient
can provide their basic medical data when arriving to the new unit. Such informa-
tion can include recent lung function history, medications, allergies, genotypes.
Scenario 2 Travelling abroad: As quality of life and survival rates increase, more
and more CF patients are travelling abroad. In this scenario if the patient would
require any medical care when travelling abroad, the mHealth passport would
ensure that the patient could provide their basic medical data (and contact infor-
mation for their healthcare team) to the attending medical professional.
Scenario 3 Bridging Gaps between the healthcare team: In Ireland, it can be
approximately 3–4 months between clinical appointments in the adult unit.
Between appointments, patients may visit a General Practitioner (GP) and begin an
antibiotic treatment and this data must be entered into their patient file at their next
clinical appointment. The details of the new antibiotics can be either forgotten, or
only partially remembered. In this scenario the app can record any interaction with
any member of their health care team as well as new prescriptions or changes to
care to provide a broader view of their care.
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It is anticipated that the app will be first offered to CF adolescents transferring to
adult care. However, it can also be suggested to any CF adult. The app will be made
available on both iOS app store and Google Play store, in addition to being made
available on the Cork Hospital CF Centre web page. Patients will be given time
during clinical appointments to enter the data with the CF nurse specialists, or they
can enter the data during non-contact time.
All data collected through the app will be stored locally on the device. It shall not
be transmitted or viewed by any other personnel. The data recorded will not be
analyzed; however, some data shall be visualized in two interactive graphs. The first
graph will display Weight over time, and the second will display lung function as
FVC% and FEV1%. An example of this graph can be seen in Figure 1. The graph is
interactive and can allow users to touch different points on the plot to view its
corresponding information. The user can also save reminders for clinical appoint-
ments or take medications through the app.
4.1.2 Application type
The proposed CF Patient Passport can be considered as both an In Vitro app and
a Wellbeing/Lifestyle app. The passport is intended to record a patient’s basic
medical information and simultaneously plot data on a graph; as such, it is consid-
ered an In Vitro app. It is not considered a Medical Device, as this data is not being
used to perform a diagnostic or any immediate decision making for the patient.
Figure 1.
Lung function (FEV1, FVC) in “My Clinic Appointments”.
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However, it can also be considered as a Wellbeing/Lifestyle app as it may improve
health behaviors among this cohort as they become more aware of their own
medical data/symptoms.
4.1.3 Ethics and regulations
All evaluations performed with patients received ethical approval from the
Clinical Research Ethics Committee in Cork. The app is currently available on the
Google Play store in Ireland and is GDPR compliant.
4.2 Back-end
To ensure that the app can be deployed to both Android and iOS, Cordova
PhoneGap [21] was used to develop the mHealth passport. PhoneGap uses web
technologies such as HTML, CSS, and JavaScript in addition to Frameworks for
navigations and layouts. For this passport, Framework 7 [22] is incorporated into
the app to ensure a consistent layout/style across both Android and iOS. The lan-
guage and dialogue used in the app is simple so that it can be understood by non-
medical persons. All graphs are developed using the Highcharts.js framework [23].
This section will discuss the validation of content and dialogue within the applica-
tion before discussing the data that can be recorded via the passport app.
4.2.1 Content and dialogue validation
As CF is a genetic disease, patients have grown up listening to and using medical
terminology to aid in the management of their condition. Therefore, the medical
data that can be recorded in the app is familiar to this cohort; however, the manner
in which the data is requested may be new to these patients, and subsequently may
require validation. A meeting was held with CF nurse specialists to discuss the
instructions on how to enter data in the app. The CF Nurse specialists were enlisted
for this task due to their extensible knowledge in communicating with this cohort.
There is no imagery used within the app, however, there are two proposed graphs.
The graphs and app instruction were modified until validation from the nurse
specialists was given.
4.2.2 Data information requirements
As the data are not being transferred and viewed by other personnel, an
opt-out service and DPA policy was not required in the app. As the CF Patient
Passport was developed as part of a pilot study, information pertaining to all inten-
tions of what data was to be collected and how it was then stored was provided to
patients in a participant information sheet. It was anticipated that once the app
was made available via app stores and over the web, these intentions would also
need to be listed.
4.2.3 Data and data analysis
Focusing on the outlined scenarios (travelling between centers, traveling
abroad, and bridging the gap between the healthcare team) a meeting was held with
the CF MDT to discuss which data should be recorded in the app to fulfill these
objectives. From this meeting it was found that the mHealth passport should follow
the same architecture as a patient file. In Ireland, a patient file can include infor-
mation stored once (genotype, date of birth, genotype etc.), information that can
sometimes be recorded (such as new medical conditions or procedures), and
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lastly data that is recorded at every clinical appointment (lung function, weight,
height etc.). Therefore the mHealth passport is separated into three core sections
and described below. To note, all data entered into the passport can be edited or
deleted if desired. These sections can be seen in Figure 2 (right).
Section 1 My CF Information: This section is targeted at the information in the
patient file that are only recorded once. This data generally describes a patient
profile such as date of diagnosis, genotype, sweat test results, allergies, contact
numbers for the healthcare team, and allergies. This can be seen in Figure 3 (left).
Section 2 My Medical History: This section is dedicated to the occasional data and
is divided into two sections. “My Medical Procedures” and “My Medical Condi-
tions”. The first section is targeted towards procedures a CF patients may have
undergone such as the insertion of a gastrostomy tube, or the removal of a
portacath. The second section focuses on new conditions or diseases which may
have developed, such as diabetes.
Section 3 My Clinic Appointments: The final section records data that are entered
into a patient file at each clinical appointment. This data can include Blood Pressure
(BP), weight, height, date, lung function (FEV1% and FVC%), bugs in mucus, new
treatments. This section can also be used for phone calls with the healthcare team,
GP Visits, and annual assessment.
4.2.4 Security operations
As the data is being stored on the smartphone, security precautions are put in
place for local storage. First, the mHealth app is password protected (as seen in
Figure 2 left). In the event of a forgotten password, a randomly generated password
is created within the app and emailed to the user. All data stored in the CF Patient
Passport is optional. Any data that is recorded is encrypted using the Advanced
Encryption Standard (AES) algorithm and stored in a local SQLite database. If the
app is uninstalled from the device, the databases will also be deleted.
Figure 2.
Login screen (left) and main menu in the passport (right).
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4.3 Front-end
In keeping with the mHealth pipeline discussed previously, the User Interface
(UI) and User Experience (UX) of the app are discussed.
4.3.1 User interface (UI)
A meeting was held with CF nurse specialists and physiotherapists to discuss the
plausibility of an Adaptive UI. From this meeting it was determined that a UI model
was not required. It was considered that perhaps an Adaptive Navigation model
may be beneficial for the use cases as described in 6.5.1 under Preparation; however,
this was later dismissed as data recorded and shown in the app is at the patient’s
discretion.
Informal discussions between the CF nurse specialists and the CF adults attend-
ing clinic found that this cohort would prefer the UI to be designed so that it does
not appear to be a mHealth app. As such, the icon that was to appear on the main
screen of the user’s smartphone does not contain any indications that the app is for
CF; hence this icon is named “My Passport”. Furthermore, the style and UI ele-
ments in the app were designed so that they do not appear to be “medical” or
“clinical”. Similarly, all menus and buttons were created to reflect the data col-
lected.
4.3.2 User experience (UX)
On reviewing diabetic patient passports, a number of issues which could prevent
the use of such of an intervention was found. Of interest to the UX aspects of this
mHealth app is outlining how the app should be implemented into the current care
system. A solution for this is discussed in Section 3.2. It is agreed by CF nurse
Figure 3.
Menu from the “My CF Info” section (left) and list of saved clinical appointments in “My Clinic Appointments”
(right).
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specialists that the app will be offered to CF adolescents transferring to CF adult
care and CF adults already registered in the hospital. If the patients are interested in
using the app a workshop will be given by nurses on how to use the app and the data
that can be recorded. The nurses will then assist the patient in entering any histor-
ical and profile data. Time is then allocated during clinical visits for patients to enter
this data with a CF nurse or during non-contact time.
4.4 Deployment
In this section, further testing and reviews conducted on the app are discussed.
Following on from the results of the reviews and testing, future plans for the
deployment of this mHealth app are outlined.
4.4.1 Stress test
The purpose of this test was to evaluate the performance of this app and its
design. Seven participants without CF were enlisted who all owned Android
devices. The decision to recruit non-CF participants was intended to identify per-
formance and design issues and to remedy them. For the stress test, participants
from a similar age range to the target CF adult cohort were chosen. Five participants
(three females and two males) between 19 and 51 were recruited. The technical
capability of this participants varied, some participants were novices at using tech-
nology, while others were ICT professionals.
The participants were asked to download the mHealth passport onto their
smartphones and test for 3 months. During this time participants were required to
enter, edit, and delete data to “My CF Information” and “My Medical History” a
minimum of once a month. However, they were requested perform the same tasks
in the “My Clinic Appointments” more frequently (once a week). Each month the
participants sent a report of any issues they encountered using the app (such as
performance, usability, or general feedback) via email.
At the end of this stress test it was found that there were no major performance
issues and the users did not find the mHealth passport difficult to use. The primary
issue reported on was a style issue that occurred on different phone screen resolu-
tions whereby the submit button to enter data would remain behind the keyboard
(users must close the keyboard before being able to submit). Another issue reported
was the lack of clarity or structure when entering dates into the mHealth app. The
final issue reported on was that the default “Go” button on the smartphone key-
board did not move to the next text field as expected. Following this feedback, the
styling was adjusted and retested on different devices to ensure the submit button
was no longer hidden, a calendar was implemented to enter in the date, and finally
functionality was created and bound to the “Go” button to ensure users could
navigate through the form items. The above solutions were implemented in prepa-
ration for pilot testing with CF adult patients.
4.4.2 Peer review
The CF Patient Passport was then presented to CF nurse specialists, CF physio-
therapists and respiratory consultants for review. During this review, the app pur-
pose, aesthetics, dialogue, content, and functionality was reviewed. Slight
modifications are recommended by the reviewers to improve the quality of data
entered and prevent errors. Examples of this feedback included the incorporation of
a drop-down menu which contains all possible bugs that can be growing in mucus as
opposed to the patient manually entering this data. Similarly, in places where
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patients must enter a date range (e.g. start date and end date) it should be possible
for the user to enter just a month and year as opposed to date, month, and year.
Overall it is agreed that the CF patient passport can be of benefit to CF adult
patients as it will allow for this cohort to always have access to their basic medical
data and become more aware of their own condition and symptoms.
4.4.3 Patient review
Following on from the stress test and peer review, ethical approval was granted
by the Clinical Research Ethics Committee in the University College Cork for pilot
testing with CF adults from the Cork University Hospital. The inclusion criteria for
this study was that patients must be 18 years old or older and own an Android
smartphone. Participation in this study was voluntary and was offered to patients
during clinical appointments over two consecutive days. Five eligible patients were
identified and recruited by the CF nurse specialists. All five patients agreed to
partake in the study; one participant was female and the remaining four were male.
Each participant was provided with an information sheet outlining the purpose of
the app, the data collected, intentions for the data, and security measures. After the
app was installed on their devices, the participants partook in a short workshop
with the CF nurse specialists, who demonstrated how to use the app. The CF nurse
specialists also assisted the participants in entering any of their historical or patient
file data into the passport app. The patients were then asked to test the app over
3 months before completing a feedback questionnaire, which was provided to them
at their next closest clinical appointment.
5. Results
During the three-month study period, one male participant lost his smartphone
and as such was unable to complete the feedback questionnaire. Of the remaining
four participants, three reported their smartphone models: a Oneplus 5, Sony Xperia
M5, and Samsung Galaxy. All four participants agreed that they were provided with
sufficient information to use the app. The participants were then asked to rate the
appearance of the app from 1 to 5 (1 being Do not Like It, 3 being Neutral, and 5
being Like It), with two participants rating the app a 3 and the remaining partici-
pants rating the appearance a 4.
During the study period all participants reported inserting data into the app.
Two participants confirmed they used the app to share their medical information.
When asked to explain this further, one participant reported using the app in a
clinical appointment. When asked to rate the difficulty of the app from 1 to 5
(1 being Difficult, 3 being Moderate, and 5 being Easy), one participant rated the
app a 5, two participants rated the app a 4, and the remaining participant rated the
app a 3. When asked which parts of the app was difficult, the participant who rated
the app a 3 reported difficulty in inputting “some information”. One other partici-
pant also advised that the built-in back button on their device caused the app to
close instead of returning to the previous page and was therefore reliant on the
built-in navigation bar. When asked which features the participant would like to
remove from the app, three participants reported none. When asked what features
the participant would like to add to the app, one participant advised they would like
for their doctor to be able to access the data or input new data remotely.
The participants were next asked to rate the helpfulness of the app from 1 to 5
(1 being Not Helpful, 3 Indifferent, and 5 being Helpful). One participant reported
a 5 for this question, two reported a 4, and one participant reported a 3. When
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asked to explain their answer, the participant who reported a 3 did not elaborate
further. However, two other participants remarked that the app is helpful as it
allows them access to their medical information:
“It’s useful to have this information in an easily accessible place”
“It’s handy for me to have my information so readily accessible”
This is further enforced in Question 10, where all participants agreed that it
was beneficial to have access to their basic medical information through the app.
When asked who the participants believe is responsible for inputting data into the
app, three participants reported that the responsibility is theirs, while one
participant believed it was the shared responsibility of the participant and their CF
treatment team. The users were then asked to explain their answer. It was found
from these answers that users believe it is their responsibility as entering data
should be at their discretion. However, one participant welcomes guidance from
their healthcare team.
“I put what I think is necessary”
“Personal info on a personal device should only be entered by the owner unless
explicit permission is given. I think I am ultimately responsible for knowing about
my condition and recording the information but I might not always know the most
important information to be recorded which is why my nurses and doctors should
also have input.”
“It’s my app and on my phone, so it’s my own responsibility to keep it updated”
One participant reported a barrier which prevented the editing of data. This
participant found that some saved data in the My CF Info section of the app could
not be edited, and instead needed to be deleted and inputted again, which they
regarded as frustrating. The participants were then asked to rate the regularity of
using the app from 1 to 5 (1 being Not Regularly, 3 being Sometimes, and 5
being Regularly). Two participants rated this question a 1, one participant reported
a 3, and the remaining participant reported a 4. When asked to list scenarios in
which they felt the app maybe useful, the participants reported the following
scenarios:
“If I got sick on holidays could show what I’m on”
“Listing medication/medical details at clinics etc”
“Sharing information with my GP or if I’m traveling and need to share information
with a doctor. Going abroad or another hospital/GP”
It can be seen from the above scenarios that participants felt that the app
maybe of most benefit when travelling abroad or sharing information with medical
and healthcare professionals. Lastly, the participants were asked to rate how ade-
quate the security precautions within the app are from 1 to 5 (1 being not adequate
and 5 being adequate), to which two participants rated a 5, and the remaining two
rated a 4.
5.1 Initial observations
It is acknowledged that some limitations of this study are the small number of
participants and the disproportionate ratio of male to female participants, which
could present a potential gender bias. There was a notable difference in the partic-
ipants reported regularity of the apps use. Patients were asked about how often they
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would use the app. At face value, not regularly could be perceived as concerning;
however, CF patients attend CF clinic appointments quarterly, and entering data is
at the patient’s discretion. In addition to this, minor issues in device functionality
were reported by this cohort, which have since been addressed and resolved.
Interestingly, unlike the findings of the paper-based patient passport, partici-
pants of this study identified themselves as the sole or major inputter of data. This is
perhaps a clear advantage to paper-based passports, which reported uncertainties in
this responsibility, as discussed previously. This may be attributed to the passport
being based on a patient’s personal device, as opposed being provided to them in a
hospital branded booklet.
Moreover, the app in its current form was received positively by the participants
of this study. All participants agreed that having access to their basic medical
information is of benefit to them. Furthermore, these patients envision practical
scenarios in which this app may be of benefit to them in the future.
6. Conclusion and future works
The app is currently available for free on the Google Play Irish store. Future
works would include deploying the app to iOS app store and being linked to the
Cork CF Centre website. Information pertaining to data usage intentions and stor-
age will is made available on the app store description page. The results of the
patient survey conducted found that this cohort showed interest in the recording
and viewing of their medical data in a convenient and manageable way. To this end,
it was found that the concept of a patient passport could prove to be a suitable
solution. Patient passports have been proven to help patients with self-management
as it facilitates the ability to closely monitor their own condition. Hence a passport
application was developed so that CF adults could record their medications and
basic CF information. It is also anticipated that this will allow these patients to
receive care when travelling between centers and abroad. A pilot study with four
participants demonstrates that CF adults perceive this passport app to be beneficial
as it allows them access to their basic medical information. It was also found
through the pilot study that participants would not use this mHealth app frequently.
This is a similar finding to paper-based passports, as patients only enter the data
into the app during clinical appointments (quarterly) and share data in specific
scenarios such as with a GP, or when travelling abroad. As the app is password
protected, the user must be able to enter in their correct credentials and navigate
through the app to share data. However, in situations such as needing to attend the
accident and emergency room, this may cause further frustration to the patient,
whereas a paper-based passport can be handed to medical professional who can
locate all data needed in order to provide care. This is perhaps one advantage of the
paper-based system over the digital mHealth app. To contend with this, future
iterations of the app may include a Generate PDF button on the main menu which
will compile all the most pertinent medical data into an A4 PDF which can be
shown to medical professionals via the device or emailed to them directly. This
suggestion can also be applied to mHealth patient passports for other conditions. It
is also noted that the data from the app is stored locally only. For this reason if the
phone became lost or stolen, it would not be possible to restore a profile onto a new
phone, in this case the user would have to re-input all their data. This design choice
was made based on the feedback from the mHealth survey regarding security and
the app connecting to other online sources. However, future iterations of this app
will implement the ability to migrate data from one smartphone to another in the
event the user purchases a new phone. Once the data has been migrated, data stored
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on the old smartphone device will be deleted. In conclusion, an mHealth
patient passport is desirable among the adult CF cohort and we believe it can have
significant impact on how patients can manage their condition and have access
to their data.
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